Roundtable #5 - AI in Bio w/ Frank Nestle - CSO @ Sanofi & David Berry - CEO @ Valo | BIOS

Guests: Frank Nestle & David Berry Frank Nestle - Global Head of Research & CSO @ Sanofi Frank Nestle is global head of research and chief scientific officer at Sanofi, with responsibility for its main therapeutic research areas of immunology and inflammation, oncology, neurology, rare diseases, hematology, and genomic medicine. Before joining Sanofi in 2016, Nestle was a professor and chair of cutaneous medicine and immunotherapy at King’s College London and practiced medicine at Guy’s and St. Thomas’ Hospital. At King’s College, he led research, translational clinical trials, and teams in dermatology, allergology, and immunology. He also held several executive roles, in particular at the Guy’s and St Thomas’ Biomedical Research Center. Nestle is a fellow of the Academy of Medical Sciences, a senior investigator emeritus at the National Institute for Health Research, and past president of the Federation of Clinical Immunology Societies. He has published over 220 scientific articles and has received several awards and honors, including the Alfred Marchionini Research Award at the 20th World Congress of Dermatology. & David Berry - General Partner @ Flagship Pioneering / Founder & CEO @ Valo Health David Berry joined Flagship Pioneering in 2005, where he is a General Partner, focusing on conceiving, creating, resourcing, and launching groundbreaking companies and where he helped create Flagship Labs, where Moderna and over 100 companies - worth over $30B in aggregate value - have launched. David has personally co-founded more than 20 companies across life sciences and sustainability, including Valo Health, where he serves as CEO. Other companies include Seres Therapeutics (NASDAQ: MCRB), T2 Biosystems (NASDAQ: TTOO), Indigo Agriculture, Evelo Biosciences (NASDAQ: EVLO), Eleven Biotherapeutics (NASDAQ: EBIO), LS9 (acquired by Renewable Energy Group), Axcella Health, and Inari Agriculture. David has been broadly recognized as a world-leading innovator: elected as a Young Global Leader by the World Economic Forum, named as Innovator of the Year by MIT Technology Review from amongst its annual TR35 list, and selected as one of 12 Innovators Reshaping Reality by the U.S. State Department, alongside pioneers such as Tim Berners-Lee. He holds over 200 patents and patent applications. David and his companies have been awarded with more than 150 additional awards and honors. David currently serves on the United Nations Sustainable Development Solutions Network (UN SDSN), where he is a Founding Leadership Council Member and co-authored the Sustainable Development Goals (SDGs)—17 goals and 169 targets that serve as the Post-2016 Development Agenda for the United Nations, as agreed upon by 193 countries. David received his M.D. from Harvard Medical School and his Ph.D. from MIT in biological engineering, through the Health Sciences and Technology program completing the fastest dual degree in the modern history of the program, during which he was awarded the Lemelson-MIT Prize award for the most inventive and innovative student at MIT. Hosts: Chris Ghadban & Drew Yashar _______________________ Join BIOS Community 🎉 Become a member, continue the conversation, connect with like-minded Life Science innovators, access exclusive resources, & invite-only events… Apply to Join —https://docs.google.com/forms/d/e/1FAIpQLSft6P6HhSwMDJbFEW9j7HU6vZwjza9PRNN5ZdSGENj7HwhL7A/viewform For More Interesting Content 💭 🦾 Website: https://www.bios.community/ 🧬 Podcast: https://open.spotify.com/show/2HmcPq9k8fYpn60F3hw6Ra?si=uH9wk7SiRAiVUeP1dmwi7Q 🧪 Medium: https://medium.com/bios-community 🩺 Twitter: https://twitter.com/bios_community 🦠 LinkedIn: https://www.linkedin.com/company/bios-community 🧠 Substack: https://bioscommunity.substack.com _______________________ BIOS: Nucleus of Life Science Innovation 🚀 Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Create Radical Advances in Human Health🌟 _____________________ Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement or recommendation by Alix Ventures, BIOS Community, or its affiliates. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. Views and opinions expressed by Alix Ventures employees are those of the employees and do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, and content sponsors.